ID   VOA1066
AC   CVCL_A1SF
DR   cancercelllines; CVCL_A1SF
DR   Millipore; SCC489
DR   Wikidata; Q105511708
RX   PubMed=33052929;
CC   Doubling time: ~35 hours (PubMed=33052929).
CC   Sequence variation: Mutation; HGNC; HGNC:11110; ARID1A; Simple; p.Asp1503fs (c.4509_4510insATGACCT); Zygosity=Unspecified (PubMed=33052929).
CC   Sequence variation: Mutation; HGNC; HGNC:11110; ARID1A; Simple; p.Gly2087Ter (c.6259G>T); Zygosity=Unspecified (PubMed=33052929).
CC   Sequence variation: Mutation; HGNC; HGNC:18040; ARID1B; Simple; p.Trp1109Ter (c.3327G>A); Zygosity=Unspecified (PubMed=33052929).
CC   Sequence variation: Mutation; HGNC; HGNC:18040; ARID1B; Simple; p.Ile1778fs (c.5334dupA); Zygosity=Unspecified (PubMed=33052929).
CC   Sequence variation: Mutation; HGNC; HGNC:17098; DICER1; Simple; p.Asp1810Tyr (c.5428G>T); ClinVar=VCV000933084; Zygosity=Heterozygous (PubMed=33052929).
CC   Omics: Deep exome analysis.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
ST   Source(s): Millipore=SCC489; PubMed=33052929
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D18S51: 12,17
ST   D21S11: 29,31.2
ST   D3S1358: 14,15
ST   D5S818: 11,15
ST   D7S820: 8,11
ST   D8S1179: 11,13
ST   FGA: 23,24
ST   Penta D: 12
ST   Penta E: 7,10
ST   TH01: 7,9.3
ST   TPOX: 9,11
ST   vWA: 16
DI   NCIt; C40156; Endometrial undifferentiated carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 9
//
RX   PubMed=33052929; DOI=10.1371/journal.pone.0240412; PMCID=PMC7556492;
RA   Wang Y.-M., Tao V.L., Shin C.Y., Salamanca C.M., Chen S.Y.-T., Chow C.,
RA   Kobel M., Ben-Neriah S., Farnell D., Steidl C., McAlpine J.N.,
RA   Gilks C.B., Huntsman D.G.;
RT   "Establishment and characterization of VOA1066 cells: an
RT   undifferentiated endometrial carcinoma cell line.";
RL   PLoS ONE 15:E0240412-E0240412(2020).
//